Aigen Investment Management’s Myriad Genetics MYGN Stock Holding History

Aigen Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Buy	+22,945	New	+$104K	0.04%	462
2021 Q1	–	Sell	-19,008	Closed	-$376K	–	798
2020 Q4	$376K	Sell	19,008 -50,514	-73%	-$816K	0.05%	485
2020 Q3	$907K	Buy	+69,522	New	+$880K	0.12%	272
2020 Q2	–	Sell	-15,728	Closed	-$225K	–	1131
2020 Q1	$225K	Buy	15,728 +15,513	+7,215%	+$328K	0.03%	673
2019 Q4	$6K	Buy	+215	New	+$5.92K	﹤0.01%	994

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aigen Investment Management's MYGN Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Myriad Genetics (MYGN) in Q2 2026: 22,945 shares worth $131K. The stake represents 0.04% of the portfolio and ranks #462 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in MYGN as recently as Q4 2020.

Aigen Investment Management first reported a position in MYGN in Q4 2019 and has held it in 5 quarters since. The position peaked at $907K in Q3 2020. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

Aigen Investment Management held 22,945 shares of Myriad Genetics worth $131K as of Q2 2026.
Myriad Genetics was a new Aigen Investment Management position in Q2 2026.
Myriad Genetics made up 0.04% of Aigen Investment Management's portfolio in Q2 2026, its #462 holding.
Aigen Investment Management first reported a position in Myriad Genetics in Q4 2019 and has held it in 5 quarters since.
Aigen Investment Management's Myriad Genetics position peaked at $907K in Q3 2020.
196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.